High out-of-pocket expenses can lead to delayed initiation, reduced adherence, or premature discontinuation, impacting therapeutic outcomes
Special considerations: children and adolescents Several GLP-1RAs, including liraglutide and dulaglutide, are approved for treating children and adolescents with type 2 diabetes
New research presented on October 8, 2025, at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM25) held in Barcelona, Spain, shows that these drugs can produce atypical tracer uptake patterns that may mimic malignancy or inflammatory disease
2021 Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, et al
Sleep, alcohol, and stress as part of the chart
SUPPORTS APPETITE AND METABOLIC FUNCTION Tirzepatide activates both GLP-1 and GIP receptors